Philip Morris International Inc

NYSE:PM   11:55:25 AM EDT
96.78
+0.26 (+0.27%)
Regulatory, Earnings Announcements

Philip Morris International Announces U.S. Food And Drug Administration Authorization Of Iqos 3 For Sale In The United States

Published: 12/07/2020 22:33 GMT
Philip Morris International Inc (PM) - Philip Morris International Announces U.S. Food and Drug Administration Authorization of Iqos 3 for Sale in the United States.
Philip Morris International Inc - Expects to File an Application Seeking a Modified Exposure Marketing Order for Iqos 3 Device.
Revenue is expected to be $7.85 Billion
Adjusted EPS is expected to be $1.37

Next Quarter Revenue Guidance is expected to be $7.82 Billion
Next Quarter EPS Guidance is expected to be $1.61

More details on our Analysts Page.